Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
48
days
AI-driven precision immunotherapy: emerging trends from AACR 2026
AuthorsYani Chen; Ming Chen; Yiqing Xi; Yun Xia; Siyuan Ma; Baoxiang Chen
Affiliations1. School of Medicine, Sun Yat-Sen University, Shenzhen, China; 2. Department of Nephrology, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China; 3. Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan, China; 4. Department of Head and Neck Surgery, Tongji Medical College, Hubei Cancer Hospital, Huazhong University of Science and Technology, Wuhan, China; 5. Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, China; 6. Electrical and Electronic Engineering, Nanyang Technological University, Singapore, Singapore; 7. Hubei Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China; 8. Clinical Center of Intestinal and Colorectal Diseases of Hubei Province, Zhongnan Hospital of Wuhan University, Wuhan, China; 9. Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Canada
54
days
Beyond hypoxia and ccRCC: the expanding universe of VHL novel targets and next-generation therapeutics
AuthorsRuiyi Deng; Boyuan Wang; Mingrui Zou; Kaiyuan Mao; Jiaheng Shang; Jianhui Qiu; Jingcheng Zhou; Hua Xu; Xin Ma; Yizhou Wang; Lin Cai; Kan Gong
Affiliations1. Department of Urology, Peking University First Hospital, Beijing, China; 2. Institute of Urology, Peking University, Beijing, China; 3. Beijing Key Laboratory of Precision Medicine and Innovative Translation for Urogenital Diseases, Beijing, China; 4. National Urological Cancer Center, Beijing, China; 5. Peking University Health Science Center, Beijing, China; 6. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China; 7. Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, China; 8. Senior Department of Urology, Chinese PLA General Hospital, Beijing, China; 9. Department of Central Laboratory, Peking University First Hospital, Beijing, China
89
days
Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
AuthorsWenwen Cheng; Silvia Gaggero; Lama Hasan Bou Issa; Aïcha Ouelkdite; Guillaume Escure; Adeline Cozzani; Yanick Njosse Tchantchou; Noémie Carlier; Emilie Wauquier; Gauthier Decool; Rémi Tilmont; Benjamin Podvin; Malo Leprohon; Mojtaba Shekarkar; Léa Fléchon; Angélina Kasprowicz; Sophie Groux-Degroote; Jérôme Moreaux; Bertrand Arnulf; Jill Corre; Céline Villenet; Ludovic Martinet; Xavier Leleu; Martin Figeac; Thierry Facon; Wenfei Jin; Suman Mitra; Salomon Manier
Affiliations1. Univ. Lille, Inserm U1366 - CNRS UMR9020, Perstim lab, CRCLille – Cancer Research Center of Lille, Lille, France; 2. CAS Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China; 3. School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; 4. Department of Hematology, Lille University Hospital, Lille, France; 5. Department of Biological Hematology, Lille University Hospital, Lille, France; 6. UMR 8576 – UGSF – Unité de Glycobiologie Structurale et Fonctionnelle, CNRS, Université de Lille, Lille, France; 7. Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France; 8. Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier, Montpellier, France; 9. Institut Universitaire de France, Paris, France; 10. Hôpital Saint-Louis, Paris, France; 11. Cancer Research Center of Toulouse, INSERM 1037, Toulouse, France; 12. Université de Lille, CHU Lille, Plate-forme de génomique fonctionnelle, Centre de Biologie et Pathologie, Lille, France; 13. Department of Hematology, University of Poitiers, Centre Hospitalier Universitaire Poitiers, Poitiers, France
123
days
Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer
AuthorsIlaria Cassotti; Vito Fiume; Paolo Gandellini; Clelia Tiziana Storlazzi
Affiliations1. Department of Biosciences, University of Milan, Milan, Italy; 2. Department of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, Bari, Italy
92
days
Mapping brain volume changes in the zQ175DN mouse model of Huntington’s disease: a longitudinal MRI study
AuthorsNicholas Vidas-Guscic; Tamara Vasilkovska; Stefanie Pluym; Joëlle van Rijswijk; Johan Van Audekerke; Haiying Tang; Ignacio Muñoz-Sanjuán; Dorian Pustina; Roger Cachope; Annemie Van der Linden; Daniele Bertoglio; Marleen Verhoye
Affiliations1. Bio-Imaging Lab, University of Antwerp, Antwerp, Belgium; 2. µNeuro Center for Excellence, University of Antwerp, Antwerp, Belgium; 3. CHDI Management, Inc., The Company that Manages the Scientific Activities of CHDI Foundation, Inc., Princeton, USA; 4. Rumi Scientific, New York, USA
118
days
Evaluating global clinical trials and development trends of antibody-drug conjugates
AuthorsJintao Hu; Cong Lai; Junjie Wang; Zi Yan; Zhihan Yuan; Chunnuan Deng; Wang He; Cheng Liu; Kewei Xu
Affiliations1. Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 2. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; 3. Guangdong Provincial Clinical Research Center for Urological Diseases, Guangzhou, China; 4. Department of Urology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, China; 5. Department of Urology, Shenshan Medical Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Shanwei, China; 6. Southern Medical University, Guangzhou, China
66
days
Intra-aortic balloon pump use and in-hospital mortality in acute myocardial infarction with Killip class III or IV: a nationwide cohort study
AuthorsLingsen You; Hao Li; Zhenzhen Lu; Yu Wang; Shanyuan Hong; Mengyao Wang; Tongtong Zang; Lihong Huang; Li Shen; Junbo Ge
Affiliations1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China; 2. National Clinical Research Center for Interventional Medicine, Shanghai, China; 3. University of Shanghai for Science and Technology (USST), Oriental Pan- Vascular Devices Innovation College, Shanghai, China; 4. State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China; 5. NHC Key Laboratory of Ischemic Heart Diseases, Shanghai, China; 6. Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China; 7. Department of Cardiology, Shidong Hospital, Shanghai, China
78
days
From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas
AuthorsWee Lee Chan; Wee Joo Chng; Qi-Jing Li
Affiliations1. Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, National University Health System, Singapore, Singapore; 2. Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research, Singapore (A*STAR), Singapore, Singapore; 3. NUS Centre for Cancer Research (N2CR), 14 Medical Drive, Centre for Translational Medicine, Singapore, Singapore; 4. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
58
days
HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs
AuthorsXu Shi; Zehua Tan; Guangxi Sun; Hao Zeng; Xingming Zhang
Affiliations1. Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, China
119
days
Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma
AuthorsHaoyu Shi; Cheng Qin; Yutong Zhao; Lirui Huang; Zeru Li; Tianyu Li; Bangbo Zhao; Weibin Wang
Affiliations1. Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2. Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 3. National Science and Technology Key Infrastructure on Translational Medicine, Peking Union Medical College Hospital, Beijing, People’s Republic of China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days